CN111671809A - Medicament for treating cancer - Google Patents

Medicament for treating cancer Download PDF

Info

Publication number
CN111671809A
CN111671809A CN202010709240.4A CN202010709240A CN111671809A CN 111671809 A CN111671809 A CN 111671809A CN 202010709240 A CN202010709240 A CN 202010709240A CN 111671809 A CN111671809 A CN 111671809A
Authority
CN
China
Prior art keywords
calcium
medicament
gardenia
treating
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010709240.4A
Other languages
Chinese (zh)
Inventor
冼启福
李兆文
何礼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sheng Qifu
Original Assignee
Sheng Qifu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sheng Qifu filed Critical Sheng Qifu
Priority to CN202010709240.4A priority Critical patent/CN111671809A/en
Publication of CN111671809A publication Critical patent/CN111671809A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/748Oldenlandia or Hedyotis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/483Gleditsia (locust)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/744Gardenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/90Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Abstract

The invention discloses a medicament for treating cancer, and belongs to the field of medicaments. The present invention adds Chinese honeylocust spine, gardenia, glabrous greenbrier rhizome, mallow and calcium on the basis of the existing medicine for treating cancer, and can improve the cure efficiency. The medicament is prepared from the following raw material medicaments in part by weight: 10-35 g of oldenlandia diffusa, 3-15g of spina gleditsiae, 0-25 g of astragalus, 0-25 g of gardenia, 0-20g of glabrous greenbrier rhizome, 5-15 g of abelmoschus manihot and 0.5-2.5g of calcium. The preparation method comprises the following steps: it can be made into powder for drinking by water, or made into oral liquid, tablet, or pill by conventional method.

Description

Medicament for treating cancer
Technical Field
The invention belongs to the field of medicaments, and particularly relates to a medicament for treating cancer.
Background
200710077779.7 discloses a Chinese herbal medicine for treating cancer, which is prepared from Chinese medicinal herbs including Chinese angelica root, dried orange peel, buffalo horn, cow-bezoar, ganoderma lucidum, notoginseng, centipede, oldenlandia, barbat skullcap, black ant, cordyceps, bird's nest, etc., and has certain effect on cancer but low efficiency.
Disclosure of Invention
The invention aims to overcome the defect of low efficiency of treating the cancer and provide a medicament for treating the cancer with more remarkable curative effect.
The technical scheme of the invention is as follows: a medicament for treating cancer is prepared from the following raw material medicines in parts by weight: 10-35 g of oldenlandia diffusa, 3-15g of spina gleditsiae, 0-25 g of astragalus, 0-25 g of gardenia, 0-20g of glabrous greenbrier rhizome, 5-15 g of abelmoschus manihot and 0.5-2.5g of calcium. The above is the amount of the dry product and is the amount of one time. The dosage of 0 means that the raw material medicine can not be used, and the effect is almost or slightly poor if individual minor medicines in the prescription developed by the old traditional Chinese medicine are not needed due to shortage of goods. The preparation method comprises the following steps: it can be made into powder for drinking by water, or made into oral liquid, tablet, or pill by conventional method.
Powder is prepared by cleaning herba Hedyotidis Diffusae, spina Gleditsiae, radix astragali, fructus Gardeniae, rhizoma Smilacis Glabrae, and Semiaquilegia, removing sand and impurities, sun drying or oven drying at low temperature to water content of 5% -7%, pulverizing with pulverizer, sieving with 100-150 mesh sieve, adding calcium powder, and packaging. When the powder is taken, the powder is taken with 100 ℃ boiled water. The powder is put into a ceramic utensil and added with a proper amount of water to be boiled for 1-9 minutes for better taking. 2-3 times per day, and 3 days for 1 treatment course. Since cancer is a chronic disease, after eating the 1 st course and the 2 nd course, the patients feel obvious improvement, and the patients need to be slowly adjusted, generally the patients can be completely good for several months, and the specific time depends on individuals and conditions, particularly psychological conditions. Many cancer patients are scared, and die from psychological fear, so the cure rate is not so high. There is an article "an understanding of cancer treatment in old traditional Chinese medicine" that most cancer patients do not die and are believed to be cured. It is recommended to go online to see this article. In reality, there are cases of treating cancer, and even women who report money in America suffer from cancer, so that the women want to spend less money, and then travel for several months to check that the cancer is not good. This suggests that cancer is believed to be treatable.
An oral liquid is prepared from herba Hedyotidis Diffusae, spina Gleditsiae, radix astragali, fructus Gardeniae, rhizoma Smilacis Glabrae, and Semiaquilegia through washing, removing sand and impurities, boiling in a ceramic container with appropriate amount of water for 3-9 min, collecting the liquid, adding water, boiling for 5-15 min, mixing with the first liquid and calcium, and aseptic packaging. The composition is administered 2-3 times per day for 3 days with 1 treatment course.
The tablet is prepared by cleaning herba Hedyotidis Diffusae, spina Gleditsiae, radix astragali, fructus Gardeniae, rhizoma Smilacis Glabrae and Semiaquilegia, removing sand and impurities, adding herba Hedyotidis Diffusae, spina Gleditsiae, radix astragali, fructus Gardeniae, rhizoma Smilacis Glabrae and Semiaquilegia into a ceramic utensil with appropriate amount of water, boiling for 3-9 min, collecting the liquid, adding appropriate amount of water, boiling for 5-15 min, mixing the liquid with the first liquid, mixing with edible filler, tabletting, drying at low temperature until the water content is less than or equal to 5%, and packaging under sterile condition. The composition is administered 2-3 times per day for 3 days with 1 treatment course.
The pill is prepared by cleaning herba Hedyotidis Diffusae, spina Gleditsiae, radix astragali, fructus Gardeniae, rhizoma Smilacis Glabrae and Semiaquilegia, removing sand and impurities, adding herba Hedyotidis Diffusae, spina Gleditsiae, radix astragali, fructus Gardeniae, rhizoma Smilacis Glabrae and Semiaquilegia into a ceramic utensil with appropriate amount of water, boiling for 3-9 min, collecting the liquid, adding appropriate amount of water, boiling for 5-15 min, mixing the liquid with the first liquid, making into pill with edible filler, oven drying at low temperature until the water content is less than or equal to 5%, and aseptically packaging. The composition is administered 2-3 times per day for 3 days with 1 treatment course.
The pharmacological and medicinal properties of the raw materials contained in the invention are analyzed as follows:
herba Hedyotidis Diffusae (academic name: Hedyotis diffusa) is a annual shavings herb with a height of 15-50 cm. Slender root, branch, white flower. The stem is somewhat square or flat cylindrical, smooth and hairless, with multiple branches emanating from the base. Spring in flowering phase. The seeds are brownish yellow, fine and have 3 edges and corners.
Its patent medicine is bitter and bland in taste and cold in nature. The main effects are clearing away heat and toxic material, relieving pain and dissipating stagnation, and promoting urination and removing dampness. It is especially good at treating various types of inflammation. In clinical practice, the compatibility of oldenlandia diffusa is found to be proper, which can cure various diseases. Alias: herba Hedyotidis Diffusae, spina Gleditsiae, herba Hedyotidis Diffusae, herba Meadowrue, herba Hedyotidis Diffusae, spina Gleditsiae, herba Serpentis , and herba Hedyotidis Diffusae.
The whole herb contains asperuloside, asperulosidic acid, deacetic acid, plantaginic acid, vicarioside, paederoside methyl ester, 6-O-p-hydroxycinnamoside methyl ester, 6-O-p-methoxycinnamoyl paederoside methyl ester, 6-O-feruloyl paederoside methyl ester, 2-methyl-3-hydroxyanthraquinone, 2-methyl-3-hydroxy-4-methoxyanthraquinone, etc., and ursolic acid, beta-sitosterol, hentriacontane, stigmasterol, oleanolic acid, beta-sitosterol-beta-glucoside, p-coumaric acid, etc.
Medicinal value, main treatment: cough and asthma due to liver heat; swollen and sore throat; intestinal abscess; furuncle, swelling, sore and ulcer; bite by poisonous snake; stranguria with heat manifested as painful urination; edema; dysentery; enteritis; jaundice due to damp-heat; it is good at treating various cancers.
The pharmacological action is as follows: 1. the product has low antibacterial potency, but obvious anti-infection effect after oral administration, and can increase phagocytic function of leukocyte by stimulating reticuloendothelial system to improve serum bactericidal power, and the phagocytic ability of leukocyte in administration group is 4 times higher than that of control group. Microscopic examination shows that the reticuloendothelial system is obviously proliferated, reticulocyte is proliferated and is hypertrophic, cytoplasm is rich, phagocytosis is active, and argentophilic substances in tissues such as lymph nodes, spleen, liver and the like are densified and changed, so that the defense function of the organism is enhanced. Can enhance humoral immunity function, and significantly increase hemolytic plaque number in mouse spleen. 2. Oldenlandia diffusa with tumor inhibition effect has inhibition effect on leukemia cells such as acute granulocyte leukemia cells and acute lymphatic leukemia cells in vivo; the oldenlandin has the functions of inhibiting and killing ascites hepatoma cells of mice, and 1 mg of oldenlandin can kill all ascites hepatoma cells of 0.2 ml within 24 hours. Herba Hedyotidis Diffusae has effects of inhibiting Wake cancer 256, cervical cancer 14, sarcoma 180, liver cancer solid type, and Ehrlich ascites carcinoma. The oldenlandia diffusa can obviously inhibit mouse sarcoma 180 cell division phase, especially mitosis phase, and cause tumor tissue necrosis. The triterpenic acid has significant inhibition effect on lymphosarcoma No. 1 ascites type, cervical cancer 14, liver cancer solid type and sarcoma 180, and the coumarins have significant inhibition effect on lymphosarcoma No. 1 ascites type and ehrlich ascites carcinoma subcutaneous type, and the oldenlandia diffusa is considered as a broad-spectrum anticancer drug, and the contained antitumor component is not one. Therefore, in the sarcoma 180 mice treated by the leucissus altivelis, besides the tumor cells are inhibited, the tissues around the tumor have lymphocyte, neutrophil infiltration, lymph node, spleen reticuloendothelial cell proliferation and liver middle lymph focus formation, and the Kupffer cell proliferation is obvious in hypertrophy. 3. The product has the effect of inhibiting the development of mouse spermatogonia into primary spermatocyte, so that seminal tubules become cavities. Clinical studies have also shown that: after the product is orally taken for 3 weeks, the number of sperms of a subject is obviously reduced. 4. Anti-snake venom effect the aqueous extract can reduce the death rate of mice poisoned by bungarus multicinctus venom.
Spina Gleditsiae, also called spina Gleditsiae, and spina Gleditsiae are spina Gleditsiae of Leguminosae arborvitae.
Nature and taste: pungent flavor and warm nature.
Meridian tropism: it enters liver and stomach meridians.
The efficacy is as follows: detumescence, expelling toxin, expelling pus, killing parasites. Has antibacterial, antiinflammatory, anticoagulant, and immunity enhancing effects.
The main treatment is as follows: can be used for treating early carbuncle and cellulitis or suppurative abscess; it is indicated for external treatment of scabies and leprosy.
Comprises the following components: the main component of the gleditsia sinensis sting is saponin.
The dosage is as follows: the general dosage is 3-15g
Contraindications are as follows:
1. it is forbidden for pregnant women.
2. Generally, it is not preferable to exceed 15g, and overdose application is prohibited.
Astragalus membranaceus, also known as astragalus membranaceus. Perennial herbs with a height of 50-100 cm. The main root is thick, woody, branched and grey-white. The stem is upright, the upper part is multi-branched, and the stem has fine edges and is white and soft. Produced in inner Mongolia, Shanxi, Gansu, Heilongjiang, etc. The astragalus root has been used for more than 2000 years, and has the functions of enhancing the immunologic function of organisms, protecting the liver, promoting urination, resisting aging, resisting stress, reducing blood pressure and having wider antibacterial action.
The astragalus contains saponin, cane sugar, polysaccharide, various amino acids, folic acid and various trace elements such as selenium, zinc, copper and the like.
Nature and taste: sweet and warm.
Meridian tropism: it enters liver, spleen, liver and kidney meridians.
The efficacy is as follows: replenishing qi to strengthen superficies, arresting sweating, promoting granulation, inducing diuresis to alleviate edema.
The main treatment is as follows: can be used for treating deficiency of vital energy, asthenia, collapse of middle-warmer energy, chronic diarrhea, proctoptosis, hematochezia, metrorrhagia, superficial deficiency, spontaneous perspiration, carbuncle, cellulitis, intractable ulcer, blood deficiency, sallow complexion, internal heat, diabetes, chronic nephritis, albuminuria, diabetes, etc.
The usage and dosage are as follows: decocting soup, decocting paste, and soaking in wine; the dosage is generally 10-20g, and the large dosage is 30-50 g.
Contraindications are as follows:
1. the book Ben Cao Jing Ji Zhu: "malignant tortoise shell". "
2. The drug Pair: "Balsamiferou Tortoise Shell" and cortex Dictamni Radicis. "
3. Medical entry & materia Medica: it is contraindicated for the patients with deep-dark and vigorous qi, but not for the patients with excessive exterior pathogen, and less for the patients with yin deficiency. "fear to prevent wind. "
4. Ben Cao Jing Shu (the book of materia Medica Prime and Dredging): "the function is excessive, and the patient with exterior pathogen does not use it; can help qi, and is not used for people with excessive qi; can be used for treating internal obstruction, deficiency, obstruction of chest and diaphragm, and stagnation of intestine and stomach; it is contraindicated for yang excess and yin deficiency; it is contraindicated for the cases with excessive heat in the upper energizer and deficiency-cold in the lower energizer; patients are angry and liver qi disharmony is avoided; it is contraindicated for acne with hot blood. "
5. The book of medical science: for excess qi, the exterior pathogen is exuberant, the skin striae and skin striae are excess, and the triple energizer fire is usually stopped. For the reason that the hands and feet are not suitable for apoplexy and phlegm is blocked and qi is blocked, the recipe is not added all the time. "
6. The New plains of materia Medica: it is contraindicated for those with steaming bone, tuberculosis and fever and fullness in middle. "
7. Materia Medica (materia Medica): chenopodium album, Oletum Trogopterori, and radix Saposhnikoviae.
8. Excessive superficial pathogenic factors, qi stagnation and dampness obstruction, food stagnation, initial carbuncle and abscess or excessive heat-toxicity after ulceration, and yin deficiency and yang hyperactivity during fever and cold are prohibited.
The function is as follows: radix astragali has effects in dilating coronary artery, improving myocardial blood supply, enhancing immunity, delaying cell aging, lowering blood pressure, regulating blood sugar, inhibiting bacteria and inhibiting virus. Radix astragali and ginseng are both good qi-tonifying herbs, radix astragali is usually combined with ginseng, and ginseng is mainly used for tonifying primordial qi and restoring yang from collapse, and is commonly used for treating acute diseases such as collapse and shock, and has good effect. While Huang Qi is mainly tonifying deficiency, it is commonly indicated for chronic weakness, low speech and weak pulse.
Gardenia also known as Gardenia jasminoides Ellis, Gardenia red and Gardenia yellow. Is fruit of Gardenia jasminoides Ellis of Rubiaceae. The fruit of gardenia is a traditional Chinese medicine, belongs to the 1 st batch of medical and edible dual-purpose resources issued by the ministry of health, and has the functions of protecting liver, benefiting gallbladder, reducing blood pressure, calming, stopping bleeding, reducing swelling and the like. Is used for treating icteric hepatitis, sprain, contusion, hypertension, diabetes and other diseases in traditional Chinese medicine clinic.
The main components are as follows: contains gardenoside, crocin, and gardenin.
The functional indications are as follows:
clear heat, purge fire, cool blood. It is used to treat febrile diseases, vexation, insomnia, jaundice, gonorrhea, diabetes, conjunctival congestion, pharyngalgia, hematemesis, epistaxis, dysentery with blood, hematuria, pyocutaneous disease, and swelling and pain.
The pharmacological action is as follows:
1. and (4) clearing away heat. Inhibit the fever center, and have a slightly similar action but a slightly weaker action than Huang Qin and Huang Lian.
2. Jaundice is removed. Has choleretic effect and can promote bile secretion. Experiments also prove that the effective component crocin crocetin of gardenia can inhibit the increase of bilirubin in blood of an animal after bile duct ligation. Gardenia liquid can cause gallbladder contraction.
3. Stopping bleeding. It has hemostatic effect after being parched to black to charcoal (charred fructus Gardeniae).
4. And (4) resisting bacteria. The in vitro test has inhibitory effect on dysentery bacillus, Staphylococcus aureus, Pseudomonas aeruginosa, etc.
5. And (5) sedation. Can be used for treating vexation and insomnia caused by brain congestion and nerve excitation due to febrile diseases. Experiments also prove that the gardenia fluid extract has a sedative effect on mice.
6. And (5) reducing the pressure. Animal experiment can lower blood pressure.
In addition, animal experiments prove that the product has an inhibiting effect on ascites tumor cells.
Smilax glabra, name of traditional Chinese medicine. Is dried rhizome of Smilax scobinicaulis C.H.Wright of Liliaceae, which is perennial evergreen climbing shrub, and is grown in hillside or under forest. The part for medicine is only selected from dried rhizome. Collected in summer and autumn, removed fibrous root, cleaned, dried and used as medicine; or cutting into slices, drying, and making into medicine. Sweet and bland in flavor and mild in nature. Has the effects of removing toxic substances, eliminating dampness, and relieving joint pain, and is mainly used for treating limb spasm and arthralgia and myalgia caused by syphilis and mercury poisoning; stranguria with turbid damp-heat, leukorrhagia, abscess, scrofula, scabies and tinea.
Nature and taste:
sweet, bland and mild.
Meridian tropism:
it enters liver and stomach meridians. Has unique curative effect on liver cancer.
The efficacy is as follows:
remove toxicity, remove dampness, and smooth joints.
The main treatment is as follows:
limb spasm, bone and muscle pain due to syphilis and mercury poisoning; stranguria with turbid damp-heat, leukorrhagia, abscess, scrofula, scabies and tinea.
Use notice:
1. wan's copy of the homeland prescription: "do not damage ironware. "
2. Compendium of materia Medica: tea should not be used when taking. "
3. The herbal supplement: it should be used with cautions for liver and kidney yin deficiency.
The Semiaquilegia adoxoides is named as traditional Chinese medicines, also called yellow cotton, jute, hemerocallis citrina baroni, fructus Rhodomyrti, bitter hemp Semiaquilegia, bitter hemp, yellow ruyi, suavena chinensis, camellia heart, yellow grass and yellow louse hemp head. Is the whole grass of Malvaceae Malvastrum coromandelaunaum (L.) Garcke (Malva coromandelaiana L.). Is distributed in Fujian, Taiwan, Guangdong, Hainan, Guangxi and Yunnan provinces. Has the effects of clearing heat, promoting diuresis, removing toxic substances and relieving swelling. It is commonly used for damp-heat diarrhea, jaundice, cough due to lung heat, swelling and pain in throat, hemorrhoid, carbuncle, sore, traumatic injury, prostatitis, and can be used for treating hepatitis by combining with Chinese Mahonia; its leaf can be used for treating sore and furuncle.
Nature and taste: slightly sweet; and (6) cooling.
Meridian tropism: a lung; liver; the large intestine channel.
The functional indications are as follows: clearing away heat, promoting diuresis, removing blood stasis and relieving swelling. It is used to treat jaundice, dysentery, malaria, infantile dyspepsia, cough due to lung heat, laryngitis, skin ulcer, furuncle, and swelling and pain due to traumatic injury. Also used for treating common cold, diarrhea, dysentery, jaundice, rheumatic arthralgia; it is used externally to treat traumatic injury, furuncle, carbuncle and swelling.
Calcium is one of the most common elements in the human body, called "in-life reinforced concrete", and accounts for 1.5-2% of the total weight of the human body, with bones and teeth accounting for about 99%. Body fluids and soft tissues account for 1%. Plays an important role in human metabolism, cell function, nervous system operation, protein hormone synthesis and the like. It is recommended to use a calcium tablet without pigment or a calcium preparation without preservative, preferably a nano-animal bone powder. The dosage of calcium is 0.5-2.5g, and the dosage of nanometer animal bone powder is 1-5g, and should not be excessive (excessive amount can cause neck swelling, hypercalcemia, hypercalcium diuresis, etc.). The calcium tablet can not be taken together with spinach and vitamin C.
The invention has the following advantages:
the invention is based on the main medicine for treating cancer, namely oldenlandia diffusa, and is added with spina gleditsiae, gardenia, glabrous greenbrier rhizome, mallow and calcium, thus improving the cure efficiency.
Detailed Description
The process of the present invention is further illustrated below with reference to examples.
Example 1: a medicament for treating cancer is prepared from 20g of oldenlandia, 15g of spina gleditsiae, 15g of astragalus root, 15g of gardenia, 10 g of glabrous greenbrier rhizome, 15g of sailflower and 1.5 g of calcium. The preparation method comprises the following steps: cleaning herba Hedyotidis Diffusae, spina Gleditsiae, radix astragali, fructus Gardeniae, rhizoma Smilacis Glabrae, and Semiaquilegia to remove sand and impurities, sun drying or oven drying at low temperature to water content of 7%, pulverizing with pulverizer, sieving with 120 mesh sieve, and adding calcium. And packaging according to the amount to obtain the finished product. When the powder is used, the preparation is put into a ceramic utensil, 600 ml of water is additionally added, the mixture is boiled for 3 minutes, the mixture is placed at a proper temperature and then taken orally, 3 times a day and 3 days for 1 course of treatment, and the powder can be stopped for 1 to 3 days between the courses of treatment. The food containing fried, roasted and mildewed food, synthetic pigment and synthetic spice is not needed to be eaten at ordinary times, people with liver diseases recommend to eat less meat, especially chicken meat is not needed to be eaten in ten millions, because the chicken meat has influence on enzyme in the liver, the meat is decomposed by the function of the liver and bile, and the burden of the liver is increased when people eat more meat; the monkeys and monkeys can eat no meat, and monosodium glutamate, wine and other spices are preferably recommended to eat no meat.
Example 2: a medicament for treating cancer is prepared from 20g of oldenlandia diffusa, 15g of spina gleditsiae, 15g of malva verticillata and 1.5 g of calcium. The preparation method comprises the following steps: cleaning herba Hedyotidis Diffusae, spina Gleditsiae, and Semiaquilegia, removing sand and impurities, boiling in a ceramic utensil with appropriate amount of water for 5 min, collecting the filtrate, adding appropriate amount of water, boiling for 9 min, mixing the filtrate with the first filtrate, adding calcium, and packaging under aseptic condition. When taken, the medicine is taken after meals every day for 3 times a day, and 3 days are taken for 1 treatment course.
Because the traditional Chinese medicine is carefully and timely adjusted, the medicine components can be increased and decreased in a certain course of treatment according to the state of illness, so that the balance of yin and yang is achieved; the medicine for treating the heat symptom is added with a spot cooling medicine, and the medicine for treating the weakness is added with a spot tonifying medicine, so the medicine can be mixed with other medicines: herba Artemisiae Scopariae and Ginseng radix Rubri can be administered together. The following examples are the administration of the agents of the present invention with additional drugs.
Example 3: a medicament for treating cancer is prepared from 15g of oldenlandia, 15g of spina gleditsiae, 15g of astragalus root, 10 g of gardenia, 15g of glabrous greenbrier rhizome, 10 g of mallow, 1.5 g of calcium, 15g of capillary wormwood herb and 15g of red ginseng. The preparation method comprises the following steps: the preparation method comprises the steps of cleaning oldenlandia diffusa, spina gleditsiae, astragalus mongholicus, gardenia, rhizoma smilacis glabrae, mallow and capillary wormwood according to the amount, removing sand and impurities, putting the materials into a ceramic utensil with a proper amount of water according to the amount, boiling for 5 minutes, taking liquid, putting the liquid in the ceramic utensil, adding a proper amount of water again, boiling for 9 minutes again, taking the liquid, adding calcium into the liquid medicine, mixing the liquid medicine and the calcium, performing the operations in a sterile environment, and performing aseptic packaging according to the amount. The composition is taken after meals every day for 3 times a day, and 3 days for 1 treatment course, with 1-3 days between treatment courses. If red ginseng is added, the medicine cannot be taken when people catch a cold, and people can eat the medicine after the cold is cured.
Typical cases are:
case 1: chen certain, male, age 18 years. Pain, cancer after going to hospital and examining, the medicament can be cured after 46 courses of treatment by introduction, and no recurrence exists at present.
Case 2: consider a woman, age 25. The cancer is detected in the hospital, and the cancer cannot be treated in the hospital due to the difficulty of families, and the cancer is cured after 53 courses of treatment by introducing the medicament, so far, the cancer does not relapse.
Case 3: suzhong, male, age 40. The cancer is detected by going to hospital, and the patient can be cured after 56 courses of treatment by introducing the medicament, and the cancer does not relapse at present.

Claims (3)

1. The medicament for treating the cancer is characterized by comprising the following raw material medicines in parts by weight: 10-35 g of oldenlandia diffusa, 3-15g of spina gleditsiae, 0-25 g of astragalus, 0-25 g of gardenia, 0-20g of glabrous greenbrier rhizome, 5-15 g of abelmoschus manihot and 0.5-2.5g of calcium. The preparation method comprises the following steps: it can be made into powder for drinking by water, or made into oral liquid, tablet, or pill by conventional method.
2. The agent for treating cancer according to claim 1, wherein: the traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: is prepared from 20g of oldenlandia diffusa, 15g of Chinese honeylocust spine, 15g of malva verticillata and 1.5 g of calcium.
3. The agent for treating cancer according to claim 1, wherein: the medicament can be taken together with capillary wormwood herb and red ginseng and comprises the following raw material medicaments in part by weight: 15g of spreading hedyotis herb, 15g of Chinese honeylocust spine, 15g of astragalus root, 10 g of gardenia, 15g of glabrous greenbrier rhizome, 10 g of sailflower, 1.5 g of calcium, 15g of capillary wormwood herb and 15g of red ginseng.
CN202010709240.4A 2020-07-16 2020-07-16 Medicament for treating cancer Pending CN111671809A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010709240.4A CN111671809A (en) 2020-07-16 2020-07-16 Medicament for treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010709240.4A CN111671809A (en) 2020-07-16 2020-07-16 Medicament for treating cancer

Publications (1)

Publication Number Publication Date
CN111671809A true CN111671809A (en) 2020-09-18

Family

ID=72457881

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010709240.4A Pending CN111671809A (en) 2020-07-16 2020-07-16 Medicament for treating cancer

Country Status (1)

Country Link
CN (1) CN111671809A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112640980A (en) * 2021-01-15 2021-04-13 陈记通 Anti-cancer herbal tea

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101313952A (en) * 2007-05-31 2008-12-03 曾广财 Traditional Chinese herb medicine for treating cancer
CN107737282A (en) * 2017-11-21 2018-02-27 冼启福 A kind of medicament for treating liver's cancer
CN109568482A (en) * 2017-09-28 2019-04-05 冼启福 A kind of medicament for treating lung cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101313952A (en) * 2007-05-31 2008-12-03 曾广财 Traditional Chinese herb medicine for treating cancer
CN109568482A (en) * 2017-09-28 2019-04-05 冼启福 A kind of medicament for treating lung cancer
CN107737282A (en) * 2017-11-21 2018-02-27 冼启福 A kind of medicament for treating liver's cancer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112640980A (en) * 2021-01-15 2021-04-13 陈记通 Anti-cancer herbal tea

Similar Documents

Publication Publication Date Title
CN105749179A (en) Traditional Chinese medicine composition for treating metabolic syndrome
CN105920514A (en) Traditional Chinese medicinal composition for treating metabolic syndrome
CN105688160A (en) Application of traditional Chinese medicine composition in preparation of drug for treating solar dermatitis
CN111671809A (en) Medicament for treating cancer
CN104367926A (en) Traditional Chinese medicine preparation for treating predawn diarrhea and preparation method thereof
CN103860773A (en) Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof
CN103705733B (en) One treats ARR Chinese medicinal capsule and preparation method thereof
CN113785981A (en) Health-preserving medicinal and edible composition and preparation method thereof
CN102885953A (en) Traditional Chinese medicine preparation for tonifying kidney and spleen and preparation process thereof
CN101293067A (en) Capsule for coronary disease
CN104127753A (en) Traditional Chinese medicine tea bag for treating gouty arthritis and preparation method thereof
CN114712470B (en) Medicine for treating deficiency of kidney of men and preparation method thereof
CN105362961A (en) Traditional Chinese medicine pill used for treating premature ovary failure and preparation method
CN105796881A (en) Medicine composition containing folium artemisiae argyi and used for treating pyemia and preparation method of medicine composition
CN106606587A (en) Blood-tonifying body-tranquillizing pharmaceutical composition
CN104491182A (en) Traditional Chinese medicine for reducing side effects of chemotherapy and preparation method
CN104689205A (en) Traditional Chinese preparation for treating insomnia and dreamful sleep and preparation method thereof
CN104825892A (en) Traditional Chinese medicine preparation for treating ovulatory bleeding and preparation method of traditional Chinese medicine preparation
CN104398849A (en) Traditional Chinese medicine composition treating dizziness
CN1131553A (en) Prescription of weifuyuan capsule and its preparation method
CN104147166B (en) Septicemia initial stage refreshing and detoxicating drink and method for making
CN113230352A (en) Health-care traditional Chinese medicine for nourishing yin and kidney and preparation method thereof
CN113057317A (en) Split ointment formula suitable for diabetes and high risk group thereof
CN114748511A (en) Medicated diet based on Guilu Erxian plaster
CN111759964A (en) Medicinal tea for nourishing and protecting liver and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200918